Insulet (PODD) Gross Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Insulet | 10.37 Bn | 9.89 Bn | 529.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 233.00 |
| Dec 31, 2025 | 708.00 |
| Sep 30, 2025 | 735.00 |
| Jun 30, 2025 | 670.00 |
| Mar 31, 2025 | 779.00 |
| Dec 31, 2024 | 808.00 |
| Sep 30, 2024 | 525.00 |
| Jun 30, 2024 | 201.00 |
| Mar 31, 2024 | 260.00 |
| Dec 31, 2023 | 396.00 |
| Sep 30, 2023 | 28.00 |
| Jun 30, 2023 | 71.00 |
| Mar 31, 2023 | 583.00 |
| Dec 31, 2022 | -214.00 |
| Sep 30, 2022 | -521.00 |
| Jun 30, 2022 | 467.00 |
| Mar 31, 2022 | 2,650.00 |
| Dec 31, 2021 | 637.00 |
| Sep 30, 2021 | 982.00 |
| Jun 30, 2021 | 1,252.00 |
| Mar 31, 2021 | 1,289.00 |
| Dec 31, 2020 | 1,535.00 |
| Sep 30, 2020 | 2,065.00 |
| Jun 30, 2020 | 1,257.00 |
| Mar 31, 2020 | 346.00 |
| Dec 31, 2019 | 1,350.00 |
| Sep 30, 2019 | 1,335.00 |
| Jun 30, 2019 | 1,606.00 |
| Mar 31, 2019 | 1,942.00 |
| Dec 31, 2018 | 1,871.00 |
| Sep 30, 2018 | 2,267.00 |
| Jun 30, 2018 | 2,145.00 |
| Mar 31, 2018 | 1,747.00 |
| Dec 31, 2017 | 1,713.00 |
| Sep 30, 2017 | 1,591.00 |
| Jun 30, 2017 | 1,514.00 |
| Mar 31, 2017 | 1,590.00 |
| Dec 31, 2016 | 1,628.00 |
| Sep 30, 2016 | 1,703.00 |
| Jun 30, 2016 | 1,264.00 |
| Mar 31, 2016 | 635.00 |
| Dec 31, 2015 | 32.00 |
| Sep 30, 2015 | -146.00 |
| Jun 30, 2015 | 729.00 |